- Coca-Cola Icecek reported a net income of 5.05 billion liras for the second quarter of 2025.
- The net income represents a year-over-year decrease of 31%.
- The reported net income surpassed analysts’ estimates, which were set at 4.95 billion liras.
- Sales for the second quarter were 48.14 billion liras, reflecting a 2.6% decline compared to the same period last year.
- Sales figures fell short of the estimated 48.67 billion liras.
- Analyst recommendations for Coca-Cola Icecek include 16 buys and 3 holds, with no sell recommendations noted.
A look at Coca-Cola Icecek Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Looking ahead, Coca-Cola Icecek AS appears to have a promising long-term outlook based on its Smart Scores analysis. With a strong focus on growth and dividends, the company seems well-positioned to drive value for investors. While its momentum score is relatively lower, the company’s resilience and overall solid performance in key areas suggest a potential for steady long-term growth.
Coca-Cola Icecek AS, a company that bottles and distributes carbonated soft drinks and noncarbonated beverages, has received positive Smart Scores in growth and dividends. This indicates a favorable outlook for the company’s future performance, highlighting its potential for sustained growth and value creation for shareholders. Despite some areas needing improvement, the overall outlook for Coca-Cola Icecek AS appears promising, making it a noteworthy company to watch in the beverage industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
